Comprehensive comparison of Botox, Dysport, Xeomin, and Jeuveau. Evidence-based information on costs, effects, safety, and 200+ years of scientific history.
Procedures performed annually
Years of scientific research
FDA-approved formulations
Global market value (2019)
Compare the four major FDA-approved botulinum toxin formulations
| Feature | Botox (onabotulinumtoxinA) |
Dysport (abobotulinumtoxinA) |
Xeomin (incobotulinumtoxinA) |
Jeuveau (prabotulinumtoxinA) |
|---|---|---|---|---|
| Manufacturer | Allergan (AbbVie) | Ipsen | Merz Pharmaceuticals | Evolus |
| FDA Approval (Cosmetic) | 2002 | 2009 | 2011 | 2019 |
| Complexing Proteins | Yes (protective proteins) | Yes (fewer proteins) | No ("naked" toxin) | Yes |
| Diffusion Rate | Moderate (penny-size) | High (quarter-size) | Low (dime-size) | Moderate |
| Onset Time | 3-5 days | 2-3 days | 4-5 days | 3-5 days |
| Duration | 3-4 months | 3-4 months | 3-6 months | 3-4 months |
| Cost per Unit (2024) | $12-20 | $4-8* | $10-17 | $8-16 |
| Typical Units Needed | 20-30 (forehead) | 40-60 (forehead)* | 20-25 (forehead) | 20-30 (forehead) |
| Best For | Precise treatment, crow's feet | Large areas, quick results | Sensitive patients, long-term use | Glabellar lines, budget-friendly |
*Dysport requires more units but costs less per unit, resulting in similar total treatment costs
The gold standard in neuromodulators. Most studied and widely used botulinum toxin with over 20 years of cosmetic use.
Known for faster onset and better diffusion, making it ideal for treating larger areas like the forehead.
The "naked" neurotoxin without accessory proteins, reducing the risk of antibody formation and resistance.
The newest FDA-approved neurotoxin, specifically developed for aesthetic use with competitive pricing.
Calculate estimated treatment costs based on your location and treatment area
*Estimates based on 2024 market averages. Actual costs may vary. Consult with a licensed provider for accurate pricing.
From deadly poison to wonder drug: The remarkable history of botulinum toxin
German physician Justinus Kerner first describes botulism symptoms and theorizes therapeutic use of what he called "sausage poison."
German physician Müller coins the term "botulism" from Latin "botulus" meaning sausage.
Belgian microbiologist Emile van Ermengem discovers and isolates Clostridium botulinum bacteria.
Dr. Herman Sommer at UCSF first isolates botulinum toxin type A in purified form.
Dr. Edward Schantz succeeds in purifying BoNT-A in crystalline form, enabling detailed study.
Dr. Vernon Brooks discovers that BoNT-A blocks acetylcholine release, leading to muscle paralysis.
Ophthalmologist Dr. Alan Scott pioneers BoNT-A use for treating strabismus (crossed eyes).
First FDA approval for botulinum toxin to treat strabismus and blepharospasm.
Drs. Jean and Alastair Carruthers notice wrinkle reduction in patients treated for blepharospasm.
FDA approves Botox for cosmetic use, launching the modern aesthetic medicine era.
Dysport (2009), Xeomin (2011), and Jeuveau (2019) receive FDA approval, providing more choices.
4.4+ million procedures annually, $5.8 billion market projected to reach $15 billion by 2030.
Comprehensive safety information and potential side effects
Most side effects resolve within 24-48 hours
Typically provider-dependent and temporary
Always inform your provider of medical conditions
Follow all post-treatment instructions
Botulinum toxin products may spread from the injection site to other areas of the body, causing symptoms similar to botulism. This has happened in children treated for spasticity but has also happened in adults. Symptoms can happen hours to weeks after injection and may include difficulty swallowing, speaking, or breathing.
Premium Domain for Sale
1M+ monthly searches
+8.2% annually
Established 2024
Contact us for pricing and transfer details
Serious inquiries only
Domain includes this complete website and all research content